Dr. Reddy’s Laboratory.
If any company is making the most news in the wake of COVID-19, it is Dr. Reddy’s Laboratories. This company launched the Russian COVID-19 vaccine Sputnik V in India. Recently, the company has recalled hundreds of thousands of bottles from the U.S. market due to some of its defects. According to a report by the US Food and Drug Administration, Dr Reddy’s is recalling 3,31,590 bottles of Cinacalcet tablets from the US market due to non-compliance with CGMP (Current Good Manufacturing Practice).
According to this report, the recall is due to the presence of an impurity in N-nitrosocinacalcet that exceeds the FDA’s interim limit. This medicine is used to treat high calcium levels in the blood and hyperparathyroidism. Not only that, the US FDA also said that the drug manufacturer is recalling 35,880 bottles and 10,584 bottles of 60 mg and 90 mg capacity respectively. It is reported that the affected batches were produced in India.
India’s second largest pharmaceutical company
Dr Reddy’s Laboratories (DRL) is a world-class pharmaceutical company. The company is also known for producing cheap and innovative drugs. It is the second largest pharmaceutical company in India. The company was founded by Indian Angie Reddy. Before starting the company, he worked with Indian Drugs and Pharmaceuticals Limited. Currently Erez Israel is the company’s CEO.
This led to the establishment of the company
In the 1980s and 1990s, India’s imports of medicines were very high and ordinary people could not afford medicines. Dr. Anji Reddy decided to change this situation. He stressed the need to produce cheap and effective medicines so that the country could become self-reliant. His company Dr. Reddy’s Laboratories has gained a good reputation in the Indian market as well as in the international market. Dr. Reddy’s has contributed immensely to the way the country exports pharmaceuticals today.
The company is listed on the New York Stock Exchange
In 1993, Dr. Reddy’s Laboratories became the first company in India to make significant advances in drug discovery and manufacturing. Since then, the company’s reputation has continued to grow, and it was listed on the New York Stock Exchange in 2001. Anji Reddy not only left his mark in the pharmaceutical industry, he was also active in the social services field from the beginning. He is known as a great philanthropist in India and abroad.
Also Read – Can new eye drops developed in India treat presbyopia? Learn from the experts
